跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
[11C]8
首页
药物
[11C]8
[11C]8
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Lipase inhibitors in deodorants and antiperspirants
申请人: HENKEL KGAA
优先权: 2002
EP
Use of N-Lauroylaminoacids as cosmetic and pharmaceutical slimming agents
申请人: SEPPIC SA
优先权: 2003
EP
PI3-kinase inhibitors
申请人: BOEHRINGER INGELHEIM INT
优先权: 2005
EP
2,4-Diaminopyrimidines as inhibitors of cell cycle kinases
申请人: BOEHRINGER INGELHEIM INT
优先权: 2007
EP
Liquid solubilizers containing ethoxylated fatty alcohol and ethoxylated triglycerides
申请人: CLARIANT INT LTD
优先权: 2007
EP
Dichloroacetate Analogs as Imaging Agents
申请人: BALATONI JULIUS A
优先权: 2008
US
Novel ligand SXH 1001 of transport protein TSPO, 18kDa as well as preparation method and application of novel ligand
申请人: ZHONGSHAN HOSPITAL XIAMEN UNIV
优先权: 2017
CN
药物
反馈